AAA
Affinity Asset Advisors’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.06M | Buy |
125,000
+100,000
| +400% | +$3.25M | 0.56% | 41 |
|
|
2025
Q1 | $944K | Hold |
25,000
| – | – | 0.09% | 66 |
|
|
2024
Q4 | $2.05M | Sell |
25,000
-25,000
| -50% | -$2.05M | 0.27% | 52 |
|
|
2024
Q3 | $5.71M | Sell |
50,000
-10,000
| -17% | -$1.14M | 0.78% | 37 |
|
|
2024
Q2 | $4.53M | Sell |
60,000
-20,000
| -25% | -$1.51M | 0.52% | 42 |
|
|
2024
Q1 | $5.46M | Buy |
80,000
+55,000
| +220% | +$3.76M | 0.68% | 38 |
|
|
2023
Q4 | $1.57M | Hold |
25,000
| – | – | 0.29% | 52 |
|
|
2023
Q3 | $1.27M | Buy |
25,000
+11,077
| +80% | +$565K | 0.36% | 43 |
|
|
2023
Q2 | $695K | Sell |
13,923
-48,300
| -78% | -$2.41M | 0.24% | 52 |
|
|
2023
Q1 | $2.33M | Buy |
62,223
+2,223
| +4% | +$83.3K | 0.77% | 31 |
|
|
2022
Q4 | $2.88M | Buy |
+60,000
| New | +$2.88M | 1.13% | 26 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$1.27M | – | 65 |
|
|
2021
Q3 | $1.27M | Hold |
50,000
| – | – | 0.32% | 46 |
|
|
2021
Q2 | $1.13M | Buy |
50,000
+20,000
| +67% | +$450K | 0.4% | 46 |
|
|
2021
Q1 | $593K | Hold |
30,000
| – | – | 0.2% | 51 |
|
|
2020
Q4 | $797K | Buy |
+30,000
| New | +$797K | 0.42% | 43 |
|